Andere talen KALA BIO, Inc. Deutsche Boerse AG

Aandelen

27F0

US4831192020

Geschatte realtime Tradegate Andere beurzen 10:42:31 03-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,243 ^EUR	-1,14%		+42,86%	-7,04%

27/06	Top stijgers in de middag	MT
27/06	Sectorupdate: Gezondheidszorgaandelen donderdag premarket gemengd	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	28/06
Top Midday Gainers	27/06
Sector Update: Health Care Stocks Mixed Premarket Thursday	27/06
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump	27/06
KALA BIO Announces $12,500,000 Private Placement	27/06
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	26/06
KALA BIO : Corporate Overview - June 2024	05/06
KALA BIO to Present at Jefferies Global Healthcare Conference	29/05
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14/05
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen KALA BIO, Inc. Deutsche Boerse AG

Aandelen

27F0

US4831192020

Andere talen

Filters